CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 41 - 50 of 826
Study Number Lead Group Study Title CIRB Study Status
10144 ETCTN A Phase II Study of Olaparib (AZD2281) in Patients with Metastatic/Advanced Urothelial Carcinoma with DNA-Repair Defects Adult CIRB - Early Phase Emphasis Available to Open
10145 ETCTN Phase IB Combination Study Of Copanlisib And Nivolumab In Advanced Solid Tumors And Lymphomas Adult CIRB - Early Phase Emphasis Available to Open
10146 ETCTN Randomized phase 2 clinical trial of nab-paclitaxel + MEDI4736 (durvalumab) + neoantigen vaccine vs. nab-paclitaxel + MEDI4736 (durvalumab) in patients with metastatic triple negative breast cancer Adult CIRB - Early Phase Emphasis Available to Open
10147 ETCTN A Phase II randomized study of topotecan/carboplatin with or without veliparib in advanced myeloproliferative disorders and chronic myelomonocytic leukemia (CMML). Adult CIRB - Early Phase Emphasis Available to Open
10150 ETCTN A randomized phase 2 study of bevacizumab and either weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant or platinum refractory ovarian cancer Adult CIRB - Early Phase Emphasis Available to Open
10166 ETCTN A Phase 2 Study of Atezolizumab and Cobimetinib in PD-1/PD-L1 Inhibitor Resistant or Refractory Non-Small Cell Lung Cancer Adult CIRB - Early Phase Emphasis Available to Open
10170 ETCTN A Phase 2 Study of AZD1775 in SETD2-Deficient Advanced Solid Tumor Malignancies Adult CIRB - Early Phase Emphasis Available to Open
10181 ETCTN A Phase 2 Study of Savolitinib in Subjects with MET Amplified Metastatic Colorectal Cancer Adult CIRB - Early Phase Emphasis Available to Open
10183 ETCTN A Pilot Study of Tazemetostat and MK-3475 (Pembrolizumab) in Advanced Urothelial Carcinoma Adult CIRB - Early Phase Emphasis Available to Open
10184 ETCTN Birinapant and Intensity Modulated Re-Irradiation Therapy (IMRRT) for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) Adult CIRB - Early Phase Emphasis Available to Open
Displaying 41 - 50 of 826